Back to top
more

Express Scripts Holding Company (ESRX)

(Delayed Data from NSDQ)

$92.33 USD

92.33
NA

0.00 (0.00%)

Updated Dec 20, 2018 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Express Scripts Introduces Medicare PDP Offerings for 2019

Express Scripts' (ESRX) Medicare PDP to initiate coverage from Jan 1, 2019. The plan includes Walmart along with CVS Pharmacy and the Kroger Family of Pharmacies.

Express Scripts' Accredo & Akcea Tie Up to Distribute TEGSEDI

Express Scripts (ESRX) likely to gain market traction through distribution of TEGSEDI.

Cigna Gets Merger Nod, Forms Management for Unified Entity

Cigna (CI) forms management as it prepares for new merged entity.

    Aetna a Step Closer to CVS Merger, Sells Medicare Business

    Aetna (AET) gets a step closer to its merger with CVS Health by selling its Medicare business to WellCare Health.

      Ryan McQueeney headshot

      Bull of the Day: Cigna (CI)

      Play this insurance giant ahead of its mega merger.

        Cigna Moves Closer to Express Scripts Buyout With DoJ Nod

        Cigna (CI) clears a significant regulatory hurdle with regards to its proposed acquisition of Express Scripts.

          Express Scripts (ESRX) Up 13.2% Since Last Earnings Report: Can It Continue?

          Express Scripts (ESRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

            Options Traders Expect Huge Moves in Express Scripts (ESRX) Stock

            Express Scripts (ESRX) needs investors to pay close attention to the stock based on moves in the options market lately.

              Regeneron (REGN) Q2 Earnings Beat on Strong Dupixent Sales

              Regeneron (REGN) reports impressive Q2 results on the back of growth in both Eylea and Dupixent sales.

                Express Scripts (ESRX) Q2 Earnings Beat, Network Claims Fall

                Express Scripts (ESRX) witnesses year-over-year decline in adjusted network claims in Q2, thanks to the loss of certain public sector clients.

                  Express Scripts (ESRX) Q2 Earnings and Revenues Top Estimates

                  Express Scripts (ESRX) delivered earnings and revenue surprises of 0.91% and 1.12%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

                    Will Revenue, Membership Growth Aid Cigna (CI) Q2 Earnings?

                    Cigna (CI) Q2 earnings is likely to gain from strong growth at its segments.

                      Will a Decline in Membership Mar Aetna's (AET) Q2 Earnings?

                      Aetna (AET) Q2 earnings to suffer from lower membership and revenues partly offset by a lower tax rate.

                        Medical Stock Q2 Earnings Due on Aug 1: ESRX, DVA & HUM

                        Solid R&D prospects likely to drive the healthcare industry in Q2 earnings.

                          Can PBM Unit Boost Express Scripts' (ESRX) Q2 Earnings?

                          Strong performance by the PBM unit is likely to drive Express Scripts' (ESRX) top line in Q2. Home-delivery pharmacy care, specialty pharmacy care and drug data analysis services buoy optimism.

                            Sweta Killa headshot

                            M&A Hits Record in 1H: Ride High With These ETFs

                            Merger and acquisition activities across the globe hit record highs in the first half of 2018 driven by growing ambition of American companies.

                              New Strong Sell Stocks for June 22nd

                              Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                Urmimala Biswas headshot

                                Walgreens-GE Faceoff: How Impactful is it for Dow Investors?

                                The stock performance of Walgreens Boots (WBA) currently does not offer much conviction. Over the past year, shares show a decline of 17.9%.

                                  New Strong Sell Stocks for June 20th

                                  Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                    Here's Why You Should Steer Clear of Express Scripts for Now

                                    Express Scripts' (ESRX) loss of major customers, downbeat 2018 earnings guidance and selling of shares to Cigna make it lower its credibility as an investment pick.

                                      Express Scripts' Inside Rx to Cut Medical Costs for the Aged

                                      Express Scripts (ESRX) keeps its commitment towards patient benefit management through subsidiary Inside Rx.

                                        Express Scripts (ESRX) Up 2.9% Since Earnings Report: Can It Continue?

                                        Express Scripts (ESRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                          Health Insurance Industry Outlook - May 2018

                                          Higher medical enrollment, surging revenues, medical cost management and an increasing share of revenues from complementary services helped results.

                                            Sweta Killa headshot

                                            Is IQ Merger Arbitrage ETF (MNA) a Hot ETF Right Now?

                                            Smart Beta ETF report for MNA

                                              Express Scripts (ESRX) Q1 Earnings Top, Patient Claims Fall

                                              Express Scripts (ESRX) witnesses year-over-year declines in patient claims in Q1, thanks to the loss of certain public sector clients.